You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oral azacitidine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
  • Oral azacitidine
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 31, 2022

Untreated Myelodysplastic Syndrome Trial in France (Onureg + Venetoclax)

Not yet recruiting
  • Untreated Myelodysplastic Syndrome
  • Onureg + Venetoclax
  • Angers, France
  • +9 more
Mar 13, 2023

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)

Active, not recruiting
  • Hematologic Neoplasm
  • Neoplasms
  • Gainesville, Florida
  • +2 more
Jan 12, 2023

T-Cell Large Granular Lymphocyte Leukemia Trial in Columbus (Oral Azacitidine)

Recruiting
  • T-Cell Large Granular Lymphocyte Leukemia
  • Oral Azacitidine
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 18, 2022

Non Hodgkin Lymphoma, Hodgkin Lymphoma, Myeloma Trial in Tampa (CC-486, Duvelisib)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 18, 2023

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Relapsed Angioimmunoblastic T-Cell Lymphoma, Refractory Angioimmunoblastic T-cell Lymphoma Trial in Worldwide (Oral azacitidine,

Active, not recruiting
  • Relapsed Angioimmunoblastic T-Cell Lymphoma
  • Refractory Angioimmunoblastic T-cell Lymphoma
  • Oral azacitidine
  • +3 more
  • Graz, Austria
  • +33 more
Aug 24, 2022

Colorectal Cancer Trial in Baltimore (Oral CC-486, Romidepsin, MK-3475)

Completed
  • Colorectal Cancer
  • Oral CC-486
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 21, 2022

MDS, Chronic Myelocytic Leukemia, Acute Myeloid Leukemia Trial in United States (Azacitidine, ASTX030 (cedazuridine +

Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +6 more
Nov 18, 2022

Leukemia, Myeloid, Acute Trial in China (CC-486, Placebo)

Recruiting
  • Leukemia, Myeloid, Acute
  • Hefei, Anhui, China
  • +31 more
Jan 10, 2023

Hepatic Insufficiency, Tumors Trial in Port Jefferson Station, Cleveland (Onureg, Vidaza)

Not yet recruiting
  • Hepatic Insufficiency
  • Neoplasms
  • Port Jefferson Station, New York
  • +1 more
Jan 13, 2022

Acute Myeloid Leukemia Trial in Japan (Oral Azacitidine, Placebo)

Recruiting
  • Acute Myeloid Leukemia
  • Oral Azacitidine
  • Placebo
  • Nagoya, Aichi, Japan
  • +30 more
May 25, 2022

Acute Myeloid Leukemia, Myelodysplasia Trial in United Kingdom (Oral azacitidine, Matched )

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • Oral azacitidine
  • Matched placebo
  • Birmingham, United Kingdom
  • +20 more
Oct 14, 2021

Lymphoma, T-Cell Trial in Charlottesville (Durvalumab, Pralatrexate, Romidepsin)

Recruiting
  • Lymphoma, T-Cell
  • Charlottesville, Virginia
    University of Virginia
Mar 16, 2022

Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Vienna, Austria
  • +3 more
Jun 8, 2023

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Previously Untreated Peripheral T-cell Lymphoma Trial in Tampa, Saint Louis, New York (CC-486 Administration, CHOP

    Active, not recruiting
    Has Results
    • Previously Untreated Peripheral T-cell Lymphoma
    • CC-486 Administration
    • CHOP Administration
    • Tampa, Florida
    • +3 more
    Jan 18, 2023

    MDS, CMML Trial in Florence (CC-486)

    Recruiting
    • MDS
    • CMML
    • Florence, Italy
      AOU Careggi- University of Florence
    Mar 16, 2021

    Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial in Duarte (Nivolumab, Oral Azacitidine)

    Recruiting
    • Recurrent Classic Hodgkin Lymphoma
    • Refractory Classic Hodgkin Lymphoma
    • Nivolumab
    • Oral Azacitidine
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    NSCLC Trial in Worldwide (CC-486, Pembrolizumab, Placebo)

    Active, not recruiting
    Has Results
    • Carcinoma, Non-Small-Cell Lung
    • Glendale, Arizona
    • +33 more
    Jan 12, 2023

    MDS, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Australia (Azacitidine, CC-486)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Newcastle, New South Wales, Australia
    • +10 more
    Mar 29, 2022

    Disease State in Adult Acute Myeloid Leukemia Receiving Oral

    Not yet recruiting
    • Acute Myeloid Leukemia
      • Medellin, Antioquia, Colombia
      • +6 more
      Oct 18, 2022